What is Glecaprevir-pibrentasvir?

Category: Prescription Drugs

Most popular types: Mavyret


Glecaprevir-pibrentasvir is a combination drug used to treat hepatitis C.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with Glecaprevir-pibrentasvir

Side effect Patients Percentage
Fatigue 1
Nausea 1
Nausea if taken on empty stomach 1
Nervousness 1

Why patients stopped taking Glecaprevir-pibrentasvir

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 1
See 1 patient who's stopped taking Glecaprevir-pibrentasvir


Stopped taking Glecaprevir-pibrentasvir

Duration Patients Percentage
Less than 1 month 1
Adherence Evaluations Percentage
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 1
Last updated:
There are no evaluations for Glecaprevir-pibrentasvir.